HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 245 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $449,389 | +122.3% | 5,432 | +140.7% | 0.00% | 0.0% |
| Q3 2023 | $202,182 | -22.2% | 2,257 | -45.1% | 0.00% | -85.7% |
| Q1 2022 | $260,000 | -33.7% | 4,111 | -44.3% | 0.01% | -41.7% |
| Q4 2021 | $392,000 | -46.7% | 7,384 | -29.1% | 0.01% | -42.9% |
| Q3 2021 | $736,000 | +94.2% | 10,421 | +139.6% | 0.02% | -50.0% |
| Q3 2020 | $379,000 | -34.2% | 4,349 | -34.0% | 0.04% | -55.8% |
| Q1 2019 | $576,000 | – | 6,590 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 538,962 | $61,927,000 | 2.21% |
| Parkman Healthcare Partners LLC | 60,250 | $6,923,000 | 2.00% |
| Bridge City Capital, LLC | 40,541 | $4,658,000 | 1.92% |
| Millrace Asset Group, Inc. | 14,665 | $1,685,000 | 1.83% |
| Nitorum Capital, L.P. | 280,586 | $32,239,000 | 1.80% |
| COOKSON PEIRCE & CO INC | 136,101 | $15,638,000 | 1.38% |
| EMERALD ADVISERS, LLC | 248,520 | $28,555,000 | 1.21% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,161 | $12,657,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,240 | $27,489,000 | 1.12% |
| Jackson Square Partners, LLC | 1,778,966 | $204,403,000 | 1.07% |